Swiss drugs firm Acino says takes on Mepha businesses
Switzerland-based pharmaceutical company Acino announced on Monday the purchase of more operations of its industry counterpart Mepha, owned by giant Teva.
Acino and Israeli firm Teva, the world's biggest generic drug maker, have agreed a deal which will see Acino take over Mepha's Asian and Latin American businesses and a research and production site in Aesch, south of Basle, a statement said.
Acino acquired Mepha's Middle East and Africa operations in October. The total cost of the acquisition is an estimated 94 million euros ($122 million).
The firm, headquartered in Basle, employs 443 people and generated annual revenues of 128 million euros in 2010.
© 2011 AFP